Take the Survey: Have Your Say on Access Conditions for New TB Drugs!

12 October 2026

New TB drugs are coming through the pipeline, but whether they reach the people who need them depends on decisions made well before rollout. A Target Access Profile (TAP) sets out, in advance, what developers and other stakeholders should do so a drug actually reaches patients — priorities that must be shaped by those most affected. The Center for Global Health Policy & Politics at Georgetown University invites community members and civil society to complete the People’s Target Access Profile (TAP) survey and help shape the access conditions for new TB drugs and regimens.

The survey is open until 20 November 2026 and can be accessed here.

To get context before taking the survey, watch the recording of the webinar held earlier in October, ‘Target Access Profiles for New TB Drugs: Bringing Community Voices into the Framework’.